title: The challenge of using SNPs in the understanding and treatment of disease.
authors.affiliation: Promega Corporation, Madison, WI 53711, USA. rschifre@promega.com
authors.forename: Richard S
authors.initials: RS
authors.lastname: Schifreen
authors.forename: Douglas R
authors.initials: DR
authors.lastname: Storts
authors.forename: Arlene M
authors.initials: AM
authors.lastname: Buller
mesh_terms: D011125:Adenomatous Polyposis Coli / Q000175:diagnosis / Q000235:genetics; D001331:Automation / Q000295:instrumentation / Q000379:methods; D001943:Breast Neoplasms / Q000175:diagnosis / Q000235:genetics; D004252:DNA Mutational Analysis / Q000295:instrumentation / Q000379:methods; D030561:Databases, Nucleic Acid; D005260:Female; D005787:Gene Frequency; D030342:Genetic Diseases, Inborn / Q000175:diagnosis* / Q000235:genetics* / Q000628:therapy; D005819:Genetic Markers; D020022:Genetic Predisposition to Disease; D014644:Genetic Variation; D005828:Genetics, Population; D015894:Genome, Human; D006239:Haplotypes; D006801:Humans; D020412:Multifactorial Inheritance; D009369:Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000235:genetics; D010597:Pharmacogenetics; D020641:Polymorphism, Single Nucleotide; D019851:Thrombophilia
chemical_list: D005819:Genetic Markers